Skip to main content
OpenTrials
Completed

NCT Number: NCT01525420

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Implementation outcomes:

* end of treatment and 6-month follow-up data retention rates; * intervention implementation quality; * number & length of calls completed.

Comparison of each arm's implementation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fred Hutchinson Cancer Research Center

Seattle, Washington, 19024, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 18 and older;
  • smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
  • wants to quit smoking in the next 30 days;
  • willing to be randomly assigned to either group;
  • willing and able to speak and read in English;
  • willing and medically eligible to use nicotine replacement therapy (NRT),
  • currently resides in the U.S., and expects to continue for at least 12 months;
  • not participating in other smoking cessation interventions;
  • has regular access to a telephone.
  • has regular access to an email address.

Exclusion criteria

  • The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:
  • another member of household enrolled in the study;
  • currently using medication or nicotine replacement products to help with quitting smoking;
  • currently using any non-cigarette tobacco products;
  • pregnant or breastfeeding;
  • had a heart attack in last 30 days;
  • within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
  • serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.

Treatment and study plan

Acceptance Therapy (ACT)

Behavioral

ACT

Cognitive behavioral therapy (CBT)

Other

CBT

Primary outcomes

  1. Number of Participants Who Stopped Smoking by 6 Month Post Treatment

    Time frame: 6 months

    30-Day point prevalence abstinence at 6 months post treatment

Secondary outcomes

  1. 7-day and 24-hour Point Prevalence Quit Rates

    Time frame: 6-month

    7-day and 24-hour point prevalence quit rates

Sponsors and collaborators

Lead sponsor

Fred Hutchinson Cancer Center

Other

Collaborators

  • Consumer Wellness Solutions

Registry information

Acronym: TALK

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Feb 3, 2012
Registry last updated
May 26, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.